A Multicenter, Observational Study to Describe the Patterns of Use and Clinical/Virologic Outcomes of Letermovir Treatment for Established Cytomegalovirus Infection in Transplant Recipients
Latest Information Update: 14 Jul 2020
At a glance
- Drugs Letermovir (Primary)
- Indications Cytomegalovirus infections
- Focus Adverse reactions; Therapeutic Use
- 14 Jul 2020 New trial record
- 03 Jun 2020 Results describing the patterns of use and clinical/virologic outcomes of letermovir treatment for established CMV infection in transplant recipients, were presented at the 2020 American Transplant Congress.